Antibiotic susceptibility of Neisseria gonorrhoeae isolates from Guangzhou, China, during 2002-2011

Japanese Journal of Infectious Diseases

Volumn 67, Issue 4, 2014, Pages 288-291

  Zheng, Heping ^a   Yang, Bin ^a   Wu, Xingzhong ^a   Huang, Jinmei ^a   Zeng, Weiying ^a   Xue, Yaohua ^a   Qin, Xiaolin ^a   Lan, Yinyuan ^a   Tang, Sanmei ^a   Ou, Jiangli ^a   Li, Yixin ^a  

^a Guangdong Provincial Center for Skin Diseases   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN DERIVATIVE; SPECTINOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; COLONY FORMING UNIT; DRUG RESISTANCE; GONORRHEA; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; ANTIBIOTIC RESISTANCE; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; CHINA; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE;

EID: 84904998644     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: 10.7883/yoken.67.288     Document Type: Article

References (29)

1. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther. 2009;7:821-34
2. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148: 606-13
3. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther. 2006;4:619-28
4. Yokoi S, Deguchi T, Ozawa T, et al. Treat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13:1275-7
5. Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England. Euro Surveill. 2001;16:pii=19833
6. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first line cefixime for gonorrhoea treatment, Norway. Euro Surveill. 2010;15:pii=;19721
7. Caá mara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012;67:1858-60
8. Unemo M, Golparian D, Nicholas R, et al. High-level cefiximeand ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56:1273-80
9. Ohnishi M, Saika T, Hoshina S, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis. 2011;17:148-9
10. Zheng HP, Cao WL, Wu XZ, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae strains isolated in Guangzhou, China, 1996-2001. Sex Transm Infect. 2003;79:399-402
11. Wu XZ, Zheng HP, Li YW, et al. In vitro susceptibility to six antimicrobial agents and the resistance plasmids genotype of Neisseria gorrhoeae isolates from four cities in Guangdong. J Diagn Ther Dermato-Venereol. 2012;19:352-5 (in Chinese)
12. NCSTD: Epidemiologic Reports of Syphilis and Gonorrheae Case Reports in China. [http://www.ncstdc.org/upfiles/201303/ 20130319152506703.pdf], accessed on 2012, 1 (in Chinese)
13. Lau JT, Kim JH, Lau M, et al. Prevalence and risk behaviors of Hong Kong males who seek cross-border same-sex partners in mainland China. Sex Transm Dis. 2004;31:568-74
14. World Health Organization (WHO). Sensitivity testing of Neisseria gonorrhoeae: Methodologies for use by participants in the WHO Western Pacific regional surveillance programme. In: WHO/WPRO Regional Antimicrobial Surevillance Working Group Meeting Proceedings. 1992;33-4
15. Chevalier B, Crenn Y, Cavallo JD, et al. Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae. Pathol Biol (Paris). 1995;43:281-3
16. Van Dyck E, Piot P, Meheus A. Bench-level laboratory manual for sexually transmitted diseases, VDT/89.443. Geneva: World Health Organization (WHO)1989.
17. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. Sex Transm Dis. 2007;34:995-9
18. Gu WM, Yang Y, Wu l. Surveillance on antibiotic susceptibility of Neisseria gonorrhoeae from 1988 to 2002 in Shanghai. Chin J Dermatol. 2004;37:323-5 (in Chinese)
19. Zhou X, Liu X, Zhang Z. Analysis of drug-resistance of Neisseria gonorrhoeae to antibiotics in Dalian from 2009-2011. China Health Care & Nutrition. 2013;1:388-9 (in Chinese)
20. Zhong N, Zheng W, Wang F, et al. Analysis on the drugresistance of Nersseria gonorrhoeae to Antibiotics in Hainan area from 2006-2011. Chin J Derm Venereol. 2013;27:56-7 (in Chinese)
21. Jabeen K, Nizamuddin S, Irfan S, et al. Increasing trend of resistance to penicillin, tetracycline, and fluoroquinolone resistance in Neisseria gonorrhoeae from Pakistan (1992-2009). J Trop Med, 2011; 960501. doi: 10.1155/2011/960501
22. Olsen B, Pham TL, Golparian D, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infect Dis. 2013;doi:10.1186/1471- 2334-13-40
23. Sethi S, Golparian D, Bala M, et al. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011. BMC Infect Dis. 2013;doi:10.1186/1471-2334-13-35
24. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009;10:555-77
25. Kirkcaldy RD, Ballard RC, Dowell D. Gonococcal resistance: are cephalosporins next? Curr Infect Dis Rep. 2011;13:196-204
26. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Exp Rev Anti Infect Ther. 2009;7:821-34
27. Centers for Disease Control and Prevention. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates-United States, 2000-2010. MMWR Morb Mortal Wkly Rep. 2011;60:873-7
28. Australian Gonococcal Surveillance Programme, Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2008. Commun Dis Intell Q Rep. 2009;33:268-74
29. Yan H, Yin YP, Dai XQ. Antimicrobial resistance in clinical isolates of Neisseria gonorrhoeae in China, 2008:an epidemiological study. Chin J Dermatol. 2011;44:472-5 (in Chinese)